December 16, 2020 (v1)
Publication
Chronic myeloid leukemia (CML) is the first cancer for which targeted therapy was shown to be effective. Tyrosine kinase inhibitors (TKIs) greatly improved most patients' quality of life but failed to completely eradicate the disease. Therefore, patients require life-long treatment that possibly come with long-term side effects. Furthermore,...
Uploaded on: December 3, 2022